Business Context and Reporting Period
This Form 8-K filing by WellPoint, Inc. (now Elevance Health, Inc.) reports on events occurring on March 1, 2006, with the report filed on March 3, 2006. The filing details the establishment of executive compensation packages for the 2006 fiscal year by the Compensation Committee of the Board of Directors.
Key Financial Metrics
The filing does not provide consolidated financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation terms.
| Executive Officer | 2006 Salary | 2006 Stock Options (#) | 2006 Restricted Stock (#) | 2006 Bonus Target (%) |
|---|---|---|---|---|
| Larry C. Glasscock | $1,300,000 | 320,000 | 40,000 | 140% |
| David C. Colby | $710,000 | 100,000 | 12,500 | 85% |
| Keith R. Faller | $680,000 | 93,333 | 11,667 | 80% |
| Joan E. Herman | $610,000 | 80,000 | 10,000 | 80% |
| John S. Watts, Jr. | $600,000 | 80,000 | 10,000 | 80% |
Stock options and restricted stock were granted at a fair market value of $76.59 per share based on the March 1, 2006 closing price. Additionally, the CEO's Directed Executive Compensation (DEC) Program benefits were increased to $42,000 in Cash Credits and $15,000 in Core Credits.
Material Changes
The filing does not provide comparative data against prior periods to quantify material changes in financial performance. The primary change reported is the formalization of 2006 executive compensation structures and the specific increase in the CEO's DEC Program benefits.
Guidance, Outlook, and Risks
Management commentary is limited to the mechanics of the compensation plan. The 2006 Annual Bonus is tied to diluted earnings per share targets, synergy goals, strategic business unit operating gains, membership growth, and individual performance. Bonuses can range from 100% of target at threshold performance to 300% at maximum performance. Cash awards are capped at 200% of the target, with excess amounts paid in restricted stock vesting over three years. No specific financial guidance or risk factors regarding market conditions are disclosed in this filing.
Investor Verification Checklist
- Verify the vesting schedules: Stock options vest in six semi-annual installments starting September 1, 2006; restricted stock vests in three annual installments starting March 1, 2007.
- Confirm the specific diluted earnings per share targets established by the Compensation Committee for the 2006 bonus calculation.
- Review the total equity dilution impact of the 683,333 stock options and 83,667 restricted stock units granted to named executives.
- Assess the alignment of the CEO's increased DEC Program benefits with overall company compensation philosophy.